Prophylactic intrapartum amnioinfusion: a randomized clinical trial.
Publication/Presentation Date
6-1-1990
Abstract
Amnioinfusion was performed in a prospective, randomized trial of 60 women in the latent phase of labor with oligohydramnios, as defined by an amniotic fluid index less than or equal to 5.0 cm. All fetuses were at least 37 weeks' gestational age, had normal baseline fetal heart rate variability, and no clinically significant fetal heart rate decelerations at the outset. Subjects in the amnioinfusion group (n = 30) were titrated to and maintained at an amniotic fluid index level greater than or equal to 8.0 cm throughout labor. In the group receiving amnioinfusion, significantly lower rates of meconium passage (p = 0.04), severe variable decelerations (p = 0.04), end-stage bradycardia (p = 0.05), and operative delivery for fetal distress (p = 0.002) occurred. Significantly higher umbilical arterial blood pH values were also noted in the infusion group (p = 0.02). We conclude that prophylactic intrapartum amnioinfusion is an important technique for the reduction of intrapartum morbidity.
Volume
162
Issue
6
First Page
1370
Last Page
1374
ISSN
0002-9378
Published In/Presented At
Strong TH Jr, Hetzler G, Sarno AP, Paul RH. Prophylactic intrapartum amnioinfusion: a randomized clinical trial. Am J Obstet Gynecol. 1990 Jun;162(6):1370-4; discussion 1374-5. doi: 10.1016/0002-9378(90)90894-d. PMID: 2193511.
Disciplines
Medicine and Health Sciences
PubMedID
2193511
Department(s)
Department of Obstetrics and Gynecology
Document Type
Article